Development and Validation of a Predictive Model for Liver Failure After Transarterial Chemoembolization Using Gadoxetic Acid-Enhanced MRI and Functional Liver Imaging Score
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new model using the functional liver imaging score (FLIS) can predict post-transarterial chemoembolization liver failure (PTLF) after TACE. This tool aids in assessing patient risk before the procedure.
Area Of Science
- Hepatology
- Radiology
- Oncology
Background
- Post-transarterial chemoembolization liver failure (PTLF) is a serious complication of transarterial chemoembolization (TACE).
- Accurate preoperative prediction of PTLF is essential for patient management and improving outcomes.
Purpose Of The Study
- To develop and validate a prediction model for PTLF risk.
- To utilize the functional liver imaging score (FLIS) derived from MRI for risk assessment.
Main Methods
- 156 patients undergoing TACE had Gadoxetic acid-enhanced MRI pre-procedure.
- Functional liver imaging score (FLIS) assessed by two radiologists.
- Logistic regression, nomogram development, and internal validation using bootstrap resampling.
Main Results
- PTLF occurred in 37.2% of patients.
- Multivariate analysis identified FLIS, portal vein thrombosis, and INR as independent predictors.
- The model showed an AUC of 0.759 with good calibration and clinical utility.
Conclusions
- A FLIS-based prediction model demonstrates effectiveness in predicting PTLF.
- This model can serve as a valuable clinical tool for preoperative risk assessment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.